Ocugen, Inc. (OCGN) is having a phenomenal run in the year so far. Shares of the company have skyrocketed 209.6% year to date against the industry’s decline of 5.6%. The significant surge can be attributed to its encouraging pipeline progress. Ocugen is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines. Image Source: Zacks Investment Research The company is developing a modifier gene therapy platform designed to fulfill the significant ...